statements about management’s expectations regarding Organon’s recent acquisition of Dermavant Sciences Ltd. (“Dermavant”) and potential regulatory approval from the FDA for the use of ...
The Jersey City, N.J., company picked up Vtama as part of its acquisition of Dermavant Sciences from Roivant Sciences last month and had been expecting a green light in atopic dermatitis by the ...
including three from its dermatology unit Dermavant. On the chopping block are DMVT-502 for vitiligo and atopic dermatitis, DMVT-503 for acne and DMVT-504 for hyperhidrosis, which Roivant said ...
Organon is paying $175 million upfront to buy Roivant's dermatology unit Dermavant and its topical psoriasis therapy Vtama, which is also under review by the FDA for atopic dermatitis. The AI ...
TD Cowen analyst Yaron Werber maintained a Buy rating on Roivant Sciences (ROIV – Research Report) today. The company’s shares ...
The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the treatment of atopic dermatitis in adults and ...
Nov. 11, 2024 — Like the Earth, the Sun likely has swirling polar vortices, according to new research. But unlike on Earth, the formation and evolution of these vortices are driven by magnetic ...
JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, today announced that the U.S. Food and ...
Canada's main stock index opened higher on Monday, helped by technology and financial shares, while investors awaited this week's key economic data to gauge the U.S. Federal Reserve's monetary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback